Hughes N C, Pfau W, Hewer A, Jacob J, Grimmer G, Phillips D H
Haddow Laboratories, Institute of Cancer Research, Sutton, Surrey, UK.
Carcinogenesis. 1993 Jan;14(1):135-44. doi: 10.1093/carcin/14.1.135.
Treatment of mouse skin with coal tar is known to initiate tumour formation, with the carcinogenic activity associated mainly with polycyclic aromatic hydrocarbons (PAHs). A sample of pharmaceutical coal tar was analysed by gas chromatography and 19 major PAHs were identified. 32P-postlabelling analysis was used to characterize those PAHs that are responsible for the DNA binding of coal tar and, by inference, its biological activity. PAHs were grouped according to their reported carcinogenic activities and applied as mixtures to mouse skin. Group A contained all of the 19 PAHs, group B seven PAHs for which there is sufficient evidence for carcinogenicity and group C 12 PAHs with only limited or inadequate evidence of carcinogenicity in experimental animals. 32P-Labelled DNA adducts formed by coal tar were resolved on TLC into a pattern of three discrete spots (2, 4 and 6) and four areas of diffuse radioactivity (1, 3, 5 and 7). By comparison of the pattern of adducts formed by coal tar with those formed by the synthetic mixtures it appeared that PAHs in group B formed coal tar-DNA adduct spots 4 and 6, and that adduct spot 2 was formed by PAHs in group C. Attempts to identify those PAHs responsible for the formation of coal tar-DNA adducts 4 and 6 were made by comparing the chromatographic mobilities of 32P-labelled coal tar-derived DNA adducts formed in mouse skin, using TLC and HPLC, with those formed by PAHs in group B. As benzo[ghi]perylene (B[ghi]P), a component of group C, has been demonstrated to exhibit significant DNA binding ability previously, the chromatographic mobility of coal tar-DNA adduct spot 2 was compared to that of the major DNA adducts formed by B[ghi]P in vivo and in vitro. It appeared that coal tar adduct spot 2 was the major adduct formed by B[ghi]P in vitro and that benzo[a]pyrene, benzo[b]fluoranthene, benzo [j]fluoranthene and benzo[k]fluoranthene contributed to the formation of adduct spot 6. None of the PAHs examined appeared to be responsible for the formation of adduct spot 4.
已知用煤焦油处理小鼠皮肤会引发肿瘤形成,其致癌活性主要与多环芳烃(PAHs)有关。采用气相色谱法对一种药用煤焦油样品进行分析,鉴定出19种主要的多环芳烃。采用32P后标记分析法来表征那些导致煤焦油与DNA结合的多环芳烃,并据此推断其生物活性。多环芳烃根据其已报道的致癌活性进行分组,并作为混合物涂抹于小鼠皮肤上。A组包含所有19种多环芳烃,B组包含7种有充分致癌证据的多环芳烃,C组包含12种在实验动物中仅有有限或不充分致癌证据的多环芳烃。煤焦油形成的32P标记的DNA加合物在薄层色谱上分离为三个离散斑点(2、4和6)的模式以及四个放射性扩散区域(1、3、5和7)。通过比较煤焦油形成的加合物模式与合成混合物形成的加合物模式,似乎B组中的多环芳烃形成了煤焦油-DNA加合物斑点4和6,而加合物斑点2是由C组中的多环芳烃形成的。通过使用薄层色谱和高效液相色谱比较在小鼠皮肤中形成的32P标记的煤焦油衍生的DNA加合物与B组中多环芳烃形成的DNA加合物的色谱迁移率,试图鉴定那些导致形成煤焦油-DNA加合物4和6的多环芳烃。由于C组的一种成分苯并[ghi]芘(B[ghi]P)先前已被证明具有显著的DNA结合能力,将煤焦油-DNA加合物斑点2的色谱迁移率与B[ghi]P在体内和体外形成的主要DNA加合物的色谱迁移率进行了比较。似乎煤焦油加合物斑点2是B[ghi]P在体外形成的主要加合物,并且苯并[a]芘、苯并[b]荧蒽、苯并[j]荧蒽和苯并[k]荧蒽促成了加合物斑点6的形成。所检测的多环芳烃似乎都与加合物斑点4的形成无关。